BIRC7 and neoplasm: We recently demonstrated that livin was positive in approximately 60% of RCC specimens, but the expression may not provide predictive information on survival.[32] However, livin may be recognized as a tumor antigen by the immune system in RCC patients because the anti-livin antibody levels in the sera of patients were significantly higher than those in healthy controls.